Properties of the minimum point of an unbalanced two-sided random walkDING, Keyue.Communications in statistics. Theory and methods. 2001, Vol 30, Num 11, pp 2393-2414, issn 0361-0926Conference Paper

Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non-Small-Cell Lung CancerFRÜH, Martin; ROLLAND, Estelle; SPIRO, Stephen et al.Journal of clinical oncology. 2008, Vol 26, Num 21, pp 3573-3581, issn 0732-183X, 9 p.Article

Erlotinib in lung cancer : Molecular and clinical predictors of outcomeTSAO, Ming-Sound; SAKURADA, Akira; MARRANO, Paula et al.The New England journal of medicine. 2005, Vol 353, Num 2, pp 133-144, issn 0028-4793, 12 p.Article

Erlotinib for Advanced Non-Small-Cell Lung Cancer in the Elderly : An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21WHEATLEY-PRICE, Paul; DING, Keyue; SEYMOUR, Lesley et al.Journal of clinical oncology. 2008, Vol 26, Num 14, pp 2350-2357, issn 0732-183X, 8 p.Article

Lung Adjuvant Cisplatin Evaluation : A Pooled Analysis by the LACE Collaborative GroupPIGNON, Jean-Pierre; TRIBODET, Hélène; SPIRO, Stephen G et al.Journal of clinical oncology. 2008, Vol 26, Num 21, pp 3552-3559, issn 0732-183X, 8 p.Article

Vinorelbine plus Cisplatin vs. Observation in resected non-small-cell lung cancerWINTON, Timothy; LIVINGSTON, Robert; FRY, Willard et al.The New England journal of medicine. 2005, Vol 352, Num 25, pp 2589-2597, issn 0028-4793, 9 p.Article

Intermittent Androgen Suppression for Rising PSA Level after RadiotherapyCROOK, Juanita M; O'CALLAGHAN, Christopher J; WARDE, Padraig et al.The New England journal of medicine. 2012, Vol 367, Num 10, pp 895-903, issn 0028-4793, 9 p.Article

Class III β-tubulin expression and benefit from adjuvant cisplatin/ vinorelbine chemotherapy in operable non-small cell lung cancer : Analysis of NCIC JBR.10SEVE, Pascal; LAI, Raymond; WHITEHEAD, Marlo et al.Clinical cancer research. 2007, Vol 13, Num 3, pp 994-999, issn 1078-0432, 6 p.Article

Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer an analysis of National Cancer Institute of Canada and intergroup trial JBR. 10 and a review of the literatureALAM, Naveed; SHEPHERD, Frances A; WINTON, Timothy et al.Lung cancer. 2005, Vol 47, Num 3, pp 385-394, issn 0169-5002, 10 p.Article

Complement Receptor 1 Gene Variants Are Associated with Erythrocyte Sedimentation RateKULLO, Iftikhar J; DING, Keyue; MANOLIO, Teri A et al.American journal of human genetics. 2011, Vol 89, Num 1, pp 131-138, issn 0002-9297, 8 p.Article

Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small-Cell Lung CancerZHU, Chang-Qi; DING, Keyue; PINTILIE, Melania et al.Journal of clinical oncology. 2010, Vol 28, Num 29, pp 4417-4424, issn 0732-183X, 8 p.Article

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non―Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 StudyGOSS, Glenwood D; ARNOLD, Andrew; ELLIS, Peter M et al.Journal of clinical oncology. 2010, Vol 28, Num 1, pp 49-55, issn 0732-183X, 7 p.Article

Economic analysis of NCIC CTG JBR.10: A randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer-A report of the working Group on economic analysis, and the lung disease site group, national Cancer Institute of Canada Clinical Trials GroupNG, Raymond; HASAN, Baktiar; INCULET, Richard et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2256-2261, issn 0732-183X, 6 p.Article

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the national cancer institute of canada clinical trials groupMOORE, Malcolm J; GOLDSTEIN, David; CAMPOS, Daniel et al.Journal of clinical oncology. 2007, Vol 25, Num 15, pp 1960-1966, issn 0732-183X, 7 p.Article